Pharmacokinetics and Residues of Danofloxacin Mesylate in Goldfish (carassius Auratus Linnaeus)

PAN Yu-shan,CAO Ji-yue,FANG Zhi-ping,WANG Xiang-ling,PAN Qian-sheng,DIANG Fang-ke,GE Jian,PENG Yu-fen
DOI: https://doi.org/10.3321/j.issn:0578-1752.2006.02.029
2006-01-01
Abstract:【Objective and method】The plasma pharmacokinetics and tissue residues of danofloxacin mesylate (DFM) were investigated in goldfish, under experimental field conditions at 20℃ after single oral gavage administration(10 mg·kg-1 b.w). The danofloxacin concentrations in plasma and tissues samples were determined by using reversed-phase high performance liquid chromatography(RP-HPLC) after liquid-liquid extraction. Ofloxacin hydrochloride was selected as internal standard. Plasma concentration-time data of DFM were best fitted using a two-compartmental open model, with absorption, distribution and elimination half-life of 0.63, 4.96 and 47.79 h, respectively. The maximal plasma concentration was 3.23 μg·ml-1, peaking at 2.73 h after dosing. Area under the plasma drug concentration-time curve from 0 to ∞ was 154 μg·h·ml-1. The mean residence time (MRT) was 58.56 h using non-compartmental analysis based on statistical moment theory. 【Results】The results indicated that the concentration of DFM in kidney, liver, plasma, muscle and skin was significantly higher than that in plasma , with elimination half-life of 33, 44, 48, 51 and 177 h, respectively. To compare with other tissues, the elimination of DFM in skin was slowest, which behaved as a reservoir tissues in goldfish. It is proposed that withdrawl period should be not less than 23 days after single oral administration (10 mg·kg-1 bw) of DMF to goldfish at 20℃, according to the maximum residue limit(MRL) of 100 mg·kg-1 in skin.
What problem does this paper attempt to address?